BR
Brian Kenneth Roberts
Chief Medical Officer

Brian Kenneth Roberts insider trades: Rezolute (RZLT) stock purchases

Chief Medical Officer, Rezolute Last trade Dec 16, 2025 20 Form 4 filings
$0
Sold, last 12 months
0 sales
$48K
Bought, last 12 months
1 buy
14
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brian reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 16, 2025RZLT↑ Buy$48K
Jun 25, 2025RZLT↑ Buy$11K
Jun 14, 2024RZLT↑ Buy$17K
Jun 14, 2024RZLT↑ Buy$12K
Jun 14, 2024RZLT↑ Buy$1K
May 23, 2024RZLT↑ Buy$20K
Mar 28, 2024RZLT↑ Buy$1K
Mar 14, 2024RZLT↑ Buy$19K
Mar 7, 2024RZLT↑ Buy$925
Feb 26, 2024RZLT↑ Buy$14K
Feb 16, 2024RZLT↑ Buy$9K
Jul 3, 2023RZLT↑ Buy$9K
May 19, 2022RZLT↑ Buy$5K
May 4, 2022RZLT↑ Buy$80K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RZLT insiders

Open-market trades in the last 12 months

About Brian Kenneth Roberts's insider trades

Brian Kenneth Roberts is Chief Medical Officer at Rezolute (RZLT). Since May 4, 2022, Brian has reported 14 open-market purchases worth $246K and no sales on SEC Form 4. In the last 12 months: 1 buy ($48K).

Their filings also include grants and awards (6 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RZLT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.